BRIEF published on 05/08/2024 at 12:35, 2 years 4 months ago Positive Results for the SOLARIS Phase 3 Trial of Olanzapine Schizophrenia Medincell SOLARIS Olanzapine TEV-'749
PRESS RELEASE published on 05/08/2024 at 12:30, 2 years 4 months ago Informations privilégiées / Autres communiqués Les résultats positifs de l'étude de phase 3 SOLARIS démontrent l'efficacité de TV-749, injection sous-cutanée mensuelle pour la schizophrénie par Teva et Medincell Santé Mentale Schizophrénie Medincell TV-749 Teva
PRESS RELEASE published on 05/08/2024 at 12:30, 2 years 4 months ago Inside Information / Other news releases Teva and Medincell announce positive Phase 3 efficacy results from SOLARIS trial evaluating TEV-'749 (olanzapine) as a once-monthly subcutaneous long-acting injectable in adults with schizophrenia Schizophrenia Medincell Teva Phase 3 Efficacy Results SOLARIS Trial
BRIEF published on 05/08/2024 at 09:05, 2 years 4 months ago Medincell Temporarily Suspends its Euronext Paris Listing Euronext Paris Press Release Financial Markets Medincell Share Suspension
BRIEF published on 05/08/2024 at 09:05, 2 years 4 months ago Medincell suspend temporairement sa cotation sur Euronext Paris Euronext Paris Marchés Financiers Communiqué De Presse Médine Partager La Suspension
PRESS RELEASE published on 05/08/2024 at 09:00, 2 years 4 months ago Inside Information / Other news releases Medincell suspends listing of shares on Euronext Paris pending press release. Innovative biopharmaceutical company developing long-acting injectable drugs Euronext Paris Biopharmaceutical Suspension Medincell Long-acting Injectable Drugs
PRESS RELEASE published on 05/08/2024 at 09:00, 2 years 4 months ago Informations privilégiées / Autres communiqués Medincell suspend la cotation de ses actions sur Euronext Paris, en attente de la publication d'un communiqué. Reprise des négociations prévue demain Euronext Paris Cotation Suspension Medincell Communiqué
Published on 09/15/2026 at 15:20, 2 minutes ago MicroVision Showcases Expanding Perception Portfolio at IAA Transportation 2026
Published on 09/15/2026 at 15:00, 22 minutes ago Bitterroot Resources Awarded US$5.22 Million by the US Dept of War for the LM Nickel-Copper Exploration Project, Michigan
Published on 09/15/2026 at 15:00, 22 minutes ago Core Silver Completes Acquisition of Arcus Development Group
Published on 09/15/2026 at 14:31, 51 minutes ago First Breach Secures Federal Explosives License for Attritible Drone Manufacturing
Published on 09/15/2026 at 15:16, 5 minutes ago EQS-Adhoc: SMA Solar Technology AG: CEO Absent Due to Illness
Published on 09/15/2026 at 15:05, 16 minutes ago Prophix® Unlocks Value for Customers with New Agent and Secure AI Ecosystem Access
Published on 09/15/2026 at 14:46, 35 minutes ago Bio-Gate AG: First Comparative Clinical Data on HyProtect™ in Trauma Care—Significantly Higher Treatment Success Rate for Infected, Non-Healed Femur Fractures
Published on 09/15/2026 at 14:45, 36 minutes ago Momentus Technologies Launches MomentusMAX, an AI Platform Built for Venues, and Brings MAX for Sales to General Availability
Published on 09/15/2026 at 14:10, 1 hour 11 minutes ago Carbon credits move into the Boardroom as Nine in Ten Buyers Report Real Business Gains
Published on 09/15/2026 at 07:00, 8 hours 21 minutes ago AXA announces its 2027-2029 strategy and financial targets
Published on 09/15/2026 at 07:00, 8 hours 21 minutes ago AXA annonce son plan stratégique 2027-2029 ainsi que ses objectifs financiers
Published on 09/14/2026 at 18:21, 21 hours ago Reporting on share buyback transactions carried out between September 7 and September 10, 2026
Published on 09/14/2026 at 18:21, 21 hours ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 7 et le 10 septembre 2026
Published on 09/14/2026 at 18:00, 21 hours 22 minutes ago Mint franchit une nouvelle étape de sa transformation BtoB : deux signatures majeures viennent conforter une stratégie de croissance récurrente en accélération
